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Perfusion culture in mini-bioreactors
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Perfusion with tangential 
flow filtration in mini-bioreactor
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Shear stress in hollow fiber Mixing 
 ATF causes 































































V1613 - Product concentration reactor
V1613 - Product concentration harvest

































Viable cell density [10^6 cells/mL]
To achieve very high cell 
density 
Lower toxic by-products Enhancement of mixing & 


















Lactate affect the cell viability and 
the cell growth 
High lactate causes low viability
Gradually lower glucose conc in feed medium 
 qgluc and qlac decreased
 Nutrient feeding optimization 
 Impeller configuration and 
optimization 
Impeller configuration affect the 
mixing and shear stress
Different impeller configurations
 increased KLa
 comparable cell viability and 
growth
 ATF  lower shear and better 
























































































































































































































Filtration  (TFF) 
Flow of cell broth in 
one direction and 
driven by a pump
Flow in alternating 
direction and driven 
by a diaphragm pump
Cell separation device  
Small volume     labour
  medium usage
Small foot print 
Challenges for mini-
bioreactors
• Cell separation device
• Optimization of oxygenation
 Hydrodynamic 
optimization              . Alternating Tangential 

















































 Maintained very high cell 
density ≈ 80 106/mL in mini-
bioreactor and 1 L bioreactor









































































































































Values normalized by the values at day 6 in 1L bioreactor
 Good agreement 
between                   




Challenge for development of 
perfusion process
• High glucose concentration in 
commercial medium  high 
lactate concentration
 Feed medium optimization
 lower lactate accumulation
HEK293 cells more sensitive than CHO cells
Batch cultures
Run #2
Run #2 – Cell density
Run #1
Run #1
Mini-BRX – Run #1
Mini-BRX – Run #21L BRX
 CSPR down to 
22 pL/cell/day
 Very high cell density 
≥ 80 x 106 cells/mL
 Viability ≥ 91 %
 Volumetric productivity 
increasing with cell density 
even at low CSPR
 3 g/L/day
Run #2 – Volumetric
productivity
 Cell specific IgG productivity 
20-35 pg/cell/day
 Similar EPO productivity
 Similar cell metabolism
